C

Cellics Therapeutics, Inc.

22 employees

Cellics is committed to saving lives and improving patients’ health using innovative biomimetic nanomedicines.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
CRS
IBD
Nanoparticles
Health Care
Coronavirus
MRSA Pneumonia
Inflammatory Diseases
Biologics
Cell Membrane Coating
Therapeutics
Infectious Diseases
Sepsis
Rhumatoid Arthritis
Macrophage

Date founded

2014

Funding rounds raised

Total raised

$3.9M

from 1 investors over 1 rounds

C

Cellics Therapeutics, Inc. raised $3.9M on October 21, 2020

Investors: CARB-X

FAQ